Valeant Pharmaceuticals announced an agreement with Walgreens aimed at reducing prescription drug prices. The deal has two separate components, the first part includes a reduction on the prices of skin and eye care prescriptions by 10% across the board.  The second agreement, to take place in the second half of 2016, will lower prices for more than 30 brand-name prescription drugs (where generics are available) by more than 50%

Read more here